Physicochemical properties of cationic nanoemulsions and liposomes obtained by microfluidization complexed with a single plasmid or along with an oligonucleotide: Implications for CRISPR/Cas technology-Reference-Cited by-同舟云学术

Physicochemical properties of cationic nanoemulsions and liposomes obtained by microfluidization complexed with a single plasmid or along with an oligonucleotide: Implications for CRISPR/Cas technology

Published:2018-11 Issue: Volume:530 Page:243-255
ISSN:0021-9797
Container-title:Journal of Colloid and Interface Science
language:en
Short-container-title:Journal of Colloid and Interface Science

Author:

Schuh Roselena S.,Poletto Édina,Fachel Flávia N.S.,Matte Ursula,Baldo Guilherme,Teixeira Helder F.

Funder

National Council for Scientific and Technological Development

FIPE/HCPA

Publisher

Elsevier BV

Subject

Colloid and Surface Chemistry,Surfaces, Coatings and Films,Biomaterials,Electronic, Optical and Magnetic Materials

Reference35 articles.

1. Cationic nanoemulsions as non-viral vectors for plasmid DNA delivery;Liu;Colloids Surf. B. Biointerfaces,2010

2. Gene delivery by liposomes;Nordling-David;Isr. J. Chem.,2013

3. Entrapment of small molecules and nucleic acid-based drugs in liposomes;Fenske;Methods Enzymol.,2005

4. Nanotechnology applied to treatment of mucopolysaccharidoses;Schuh;Expert Opin. Drug Deliv.,2016

5. Investigation of the structural organization of cationic nanoemulsion/antisense oligonucleotide complexes;Bruxel;Colloids Surfaces B, Biointerfaces,2013

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging role of nanocrystals in pharmaceutical applications: A review of regulatory aspects and drug development process;Applied Materials Today;2024-10

2. Nanoliposomes as nonviral vectors in cancer gene therapy;MedComm;2024-06-25

3. Liposomes;Bioactive Delivery Systems for Lipophilic Nutraceuticals;2023-06-26

4. Molecular and Cellular In Utero Therapy;Clinics in Perinatology;2022-12

5. Gene editing strategies to treat lysosomal disorders: The example of mucopolysaccharidoses;Advanced Drug Delivery Reviews;2022-12